AbbVie expands Oxford R&D facility in £120m UK life sciences investment Manufacturing Chemist 1d Pharma Biotech Biotechnology All sources
Prediction: AbbVie's next blockbuster is hiding in a two-drug Crohn's combo The Motley Fool 8d Skyrizi Crohn Pharma
Billionaire ken griffin is buying this Dividend King that wall street still rates a buy The Motley Fool 06:42 Mon, 26 Oct Pharma
AbbVie’s skin disease drug posts Phase III win as market competition heats up Clinical Trials Arena 12:57 Fri, 23 Oct Phase III Biotech Pharma
Very low protein intake linked to higher death risk in chronic kidney disease Korea Biomedical Review 2h Pharma Science
Imlifidase enables kidney transplantation with graft survival in highly sensitized candidates Renal and Urology News 19h
Living alone linked to increased risk for death from multiple causes Renal and Urology News 19h Science
